This page is part of the C-CDA on FHIR Implementation Guide (v2.0.0: STU 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
The following is a high-level list of changes since version 1.2.0 STU1.
New Resources / Guidance
Updated Mappings
During the 2023 & 2024 connectathons, several mappings were enhanced. These updates addressed gaps for fields required by C-CDA or USCDI and included non-controversial mappings. For guidance on handling unmapped fields, refer to the Missing Maps section.
approachSiteCode, maxDoseQuantity, administrationUnitCode, manufacturerOrganization, Drug Vehicle, andSupply.raceCode/originalText as well as mappings for religiousAffiliationCode, guardian, birthPlace, languageCommunication/modeCode, languageCommunication/proficiencyLevelCode, and providerOrganization.Age Observation and Supporting Observations (e.g. Assessment Scale Observation).Additionally, all highlighted examples have been converted to inline HTML to facilitate searching, resizing, and copy-pasting.